{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T09:21:27Z","timestamp":1773912087119,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["227516\/Z\/23\/Z"],"award-info":[{"award-number":["227516\/Z\/23\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clinme.2025.100531","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T10:12:02Z","timestamp":1763374322000},"page":"100531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating hepatocellular carcinoma (HCC) surveillance through an early diagnostic centre: An implementation science approach at a tertiary hepatology centre in England"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1361-9692","authenticated-orcid":false,"given":"Hamzah Z.","family":"Farooq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Galono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3727-6708","authenticated-orcid":false,"given":"Leila","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Dearden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham R.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clinme.2025.100531_bib0001","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.clinme.2025.100531_bib0002","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"Galle","year":"2018","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.clinme.2025.100531_bib0003","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: Cancer J Clin"},{"key":"10.1016\/j.clinme.2025.100531_bib0004","year":"2023"},{"key":"10.1016\/j.clinme.2025.100531_bib0005","unstructured":"NICE (2017) - Liver disease: quality standard [QS152] \u2013 quality statement 4: surveillance for hepatocellular carcinoma. 2019. https:\/\/www.nice.org.uk\/guidance\/qs152\/chapter\/quality-statement-4-surveillance-for-hepatocellular-carcinoma."},{"issue":"6","key":"10.1016\/j.clinme.2025.100531_bib0006","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clinme.2025.100531_bib0007","first-page":"14","article-title":"BASL guidelines for the surveillance, diagnosis and treatment of hepatocellular carcinoma","volume":"67","author":"Van Vlierberghe","year":"2004","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.clinme.2025.100531_bib0008","article-title":"Hepatocellular carcinoma surveillance in the telehealth era: a single-centre review","author":"Hui","year":"2023","journal-title":"J Telemed Telecare"},{"issue":"6","key":"10.1016\/j.clinme.2025.100531_bib0010","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jhep.2020.07.025","article-title":"aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis","volume":"73","author":"Fan","year":"2020","journal-title":"J Hepatol"},{"issue":"1 SUPPL","key":"10.1016\/j.clinme.2025.100531_bib0011","first-page":"97A","article-title":"Amap risk score predicts hepatocellular carcinoma development in chronic hepatitis patients: an international cohort collaboration","volume":"72","author":"Fan","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.clinme.2025.100531_bib0012","series-title":"Census 2021, Statistical geographies","year":"2024"},{"key":"10.1016\/j.clinme.2025.100531_bib0014","series-title":"Care DoHaS","article-title":"National cost collection for the NHS","author":"England","year":"2023"},{"issue":"1","key":"10.1016\/j.clinme.2025.100531_bib0015","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.amjsurg.2022.09.051","article-title":"Utilization of a rapid diagnostic centre during the COVID-19 pandemic reduced diagnostic delays in breast cancer","volume":"225","author":"Ko","year":"2023","journal-title":"Am J Surg"},{"issue":"24","key":"10.1016\/j.clinme.2025.100531_bib0016","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1001\/jama.285.24.3107","article-title":"Policy analysis of cervical cancer screening strategies in low-resource settings \u2013 clinical benefits and cost-effectiveness","volume":"285","author":"Goldie","year":"2001","journal-title":"JAMA - J Am Med Assoc"},{"issue":"20","key":"10.1016\/j.clinme.2025.100531_bib0017","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1056\/NEJMsa044278","article-title":"Cost-effectiveness of cervical-cancer screening in five developing countries","volume":"353","author":"Goldie","year":"2005","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.clinme.2025.100531_bib0018","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s41416-020-01207-7","article-title":"The effectiveness of the Guy's Rapid Diagnostic Clinic (RDC) in detecting cancer and serious conditions in vague symptom patients","volume":"124","author":"Dolly","year":"2021","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.clinme.2025.100531_bib0019","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.20963","article-title":"Screening for hepatocellular carcinoma and survival in patients with cirrhosis after Hepatitis C virus cure","volume":"7","author":"Mezzacappa","year":"2024","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1016\/j.clinme.2025.100531_bib0020","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyz174","article-title":"Cohort profile: East London Genes & Health (ELGH), a community-based population genomics and health study in British Bangladeshi and British Pakistani people","volume":"49","author":"Finer","year":"2020","journal-title":"International Journal of Epidemiology"},{"key":"10.1016\/j.clinme.2025.100531_bib0021","unstructured":"NHS England (2013) -A call to action (Updated 2018). https:\/\/www.england.nhs.uk\/london\/2013\/11\/29\/ldn-hlth-care-lead-frm\/#:~:text=The%20London%20%E2%80%93%20A%20Call%20to,billion%20funding%20gap%20by%202020."},{"issue":"1","key":"10.1016\/j.clinme.2025.100531_bib0022","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.50211","article-title":"Estimated indirect cost savings of using telehealth among nonelderly patients with cancer","volume":"6","author":"Patel","year":"2023","journal-title":"JAMA Network Open"},{"issue":"7","key":"10.1016\/j.clinme.2025.100531_bib0023","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/annonc\/mdz140","article-title":"Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications","volume":"30","author":"Witte","year":"2019","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.clinme.2025.100531_bib0024","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/MLR.0000000000000151","article-title":"Annual patient time costs associated with medical care among cancer survivors in the United States","volume":"52","author":"Yabroff","year":"2014","journal-title":"Med Care"},{"issue":"12","key":"10.1016\/j.clinme.2025.100531_bib0025","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1634\/theoncologist.2015-0110","article-title":"Distance as a barrier to cancer diagnosis and treatment: review of the literature","volume":"20","author":"Ambroggi","year":"2015","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.clinme.2025.100531_bib0026","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/153056203772744680","article-title":"The impact of telemedicine on patients' cost savings: some preliminary findings","volume":"9","author":"Bynum","year":"2003","journal-title":"Telemed J e-health"},{"key":"10.1016\/j.clinme.2025.100531_bib0027","article-title":"COVID-19 pandemic impact on the potential exacerbation of screening mammography disparities: a population-based study in Ontario, Canada","volume":"37","author":"Fu","year":"2024","journal-title":"Prevent Med Rep"},{"issue":"2","key":"10.1016\/j.clinme.2025.100531_bib0028","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1093\/bjs\/znab426","article-title":"Impact of the COVID-19 pandemic on breast cancer referrals and diagnoses in 2020 and 2021: population-based study in England","volume":"109","author":"Gathani","year":"2022","journal-title":"Br J Surg"},{"issue":"9","key":"10.1016\/j.clinme.2025.100531_bib0029","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/s41416-022-01714-9","article-title":"The projected impact of the COVID-19 lockdown on breast cancer deaths in England due to the cessation of population screening: a national estimation","volume":"126","author":"Duffy","year":"2022","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.clinme.2025.100531_bib0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/jamaoncol.2022.5481","article-title":"Rates of routine cancer screening and diagnosis before vs after the COVID-19 pandemic","volume":"9","author":"Oakes","year":"2023","journal-title":"JAMA Oncol"},{"issue":"10","key":"10.1016\/j.clinme.2025.100531_bib0031","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/cid\/ciab379","article-title":"Transient reductions in Human Immunodeficiency Virus (HIV) clinic attendance and food security during the coronavirus disease 2019 (COVID-19) pandemic for people living with HIV in 4 African countries","volume":"73","author":"Dear","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.clinme.2025.100531_bib0032","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1186\/s12913-023-10395-w","article-title":"The impact of the COVID-19 pandemic on rates and predictors of missed hospital appointments in multiple outpatient clinics of The Royal Hospital, Sultanate of Oman: a retrospective study","volume":"23","author":"Alawadhi","year":"2023","journal-title":"BMC Health Services Res"},{"issue":"8","key":"10.1016\/j.clinme.2025.100531_bib0033","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-060961","article-title":"Impact of COVID-19 on outpatient appointments in children and young people in England: an observational study","volume":"12","author":"Bottle","year":"2022","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.clinme.2025.100531_bib0034","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.23504","article-title":"Barriers to surveillance for hepatocellular carcinoma in a multicenter cohort","volume":"5","author":"Parikh","year":"2022","journal-title":"JAMA Network Open"},{"issue":"5","key":"10.1016\/j.clinme.2025.100531_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2020.06.049","article-title":"Patient-reported barriers are associated with receipt of hepatocellular carcinoma surveillance in a multicenter cohort of patients with cirrhosis","volume":"19","author":"Singal","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.clinme.2025.100531_bib0036","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/hep4.1735","article-title":"Hepatocellular carcinoma screening process failures in patients with cirrhosis","volume":"5","author":"Marquardt","year":"2021","journal-title":"Hepatol Commun."},{"issue":"2","key":"10.1016\/j.clinme.2025.100531_bib0037","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12029-019-00255-4","article-title":"Hepatocellular carcinoma surveillance in a cohort of chronic Hepatitis C virus-infected patients with cirrhosis","volume":"51","author":"Abara","year":"2020","journal-title":"J Gastrointestinal Cancer"},{"issue":"2","key":"10.1016\/j.clinme.2025.100531_bib0038","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.31309","article-title":"Use of hepatocellular carcinoma surveillance in patients with cirrhosis: a systematic review and meta-analysis","volume":"73","author":"Wolf","year":"2021","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.clinme.2025.100531_bib0039","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s11606-011-1952-x","article-title":"Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review","volume":"27","author":"Singal","year":"2012","journal-title":"J General Internal Med"},{"issue":"1","key":"10.1016\/j.clinme.2025.100531_bib0040","doi-asserted-by":"crossref","first-page":"90.e1","DOI":"10.1016\/j.amjmed.2014.07.027","article-title":"Racial, social, and clinical determinants of hepatocellular carcinoma surveillance","volume":"128","author":"Singal","year":"2015","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.clinme.2025.100531_bib0041","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/hep.23615","article-title":"Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States","volume":"52","author":"Davila","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clinme.2025.100531_bib0042","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/hep.28765","article-title":"Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis","volume":"65","author":"Goldberg","year":"2017","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clinme.2025.100531_bib0043","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jhep.2020.05.045","article-title":"Challenges associated with the roll-out of HCC surveillance in sub-Saharan Africa \u2013 the case of Uganda","volume":"73","author":"Van Hees","year":"2020","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.clinme.2025.100531_bib0044","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S1470-2045(24)00292-4","article-title":"Call for actions to address hepatocellular carcinoma in sub-Saharan Africa","volume":"25","author":"Adepoju","year":"2024","journal-title":"Lancet Oncol"},{"issue":"8b","key":"10.1016\/j.clinme.2025.100531_bib0045","first-page":"35","article-title":"Hepatocellular carcinoma: epidemiology, pathogenesis and surveillance - implications for sub-Saharan Africa","volume":"108","author":"Zakharia","year":"2018","journal-title":"S Afr Med J"},{"key":"10.1016\/j.clinme.2025.100531_bib0046","doi-asserted-by":"crossref","DOI":"10.1007\/s12029-024-01089-5","article-title":"Hepatocellular carcinoma in Asia: physician and patient perspectives on surveillance, diagnosis, and treatment","author":"Mohamed","year":"2024","journal-title":"J Gastrointestinal Cancer"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211825002490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211825002490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T04:55:30Z","timestamp":1773896130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211825002490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1470211825002490"],"URL":"https:\/\/doi.org\/10.1016\/j.clinme.2025.100531","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating hepatocellular carcinoma (HCC) surveillance through an early diagnostic centre: An implementation science approach at a tertiary hepatology centre in England","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinme.2025.100531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of Royal College of Physicians.","name":"copyright","label":"Copyright"}],"article-number":"100531"}}